Nanjing health insurance fixed-point retail pharmacies began to implement 4 plus 7.

With the implementation of the price of 4 plus 7, the price of medical insurance payment adjustment, equal to all health insurance fixed-point retail drugstore prices should also be fully adjusted.
▍ hospital pharmacies, at the same time price adjustment It is known that from today, 4 plus 7 related varieties in Nanjing health insurance retail drugstore prices have been adjusted to achieve the hospital "the same price."
Saeber Blue exclusive ly inglison was informed that Jiangsu Pharmaceutical Company's big pharmacy announced today (December 23) that the implementation of the price of 4 plus 7 from now, the price of gifidini tablets (Ireco) adjusted to 257 yuan, methicillate Imartini tablets (Wei Wei) price adjusted to 623 yuan.

the price of the above-mentioned products in the company's store system has been adjusted to the same price as the hospital.
and the winning bid price shown in the figure below is the maximum amount that Health Insurance can swipe, and if it is exceeded, the customer can only pay at the extra cost.

it is understood that as long as the price adjustment of medical insurance payment in Nanjing area, all medical insurance fixed-point institutions in Nanjing are implemented in accordance with the adjustment price.
at present, Jiangsu Provincial People's Hospital has also issued a notice, will be on time to follow up on the price of 4 plus 7.

as early as November 7, Jiangsu Province Medical Security Bureau and other 9 departments jointly issued the "on the issuance of Jiangsu Province to promote the implementation of the state-organized centralized procurement of drugs and the use of pilot expansion of regional-wide implementation program."
it clearly mentions that Jiangsu Province will fully implement the results of the national pilot expansion and various supporting policies by December 31, 2019.
from the current situation of hospitals and health insurance retail pharmacies, indeed, is also in accordance with the prescribed time.
query the net database of the drugstore sandals found that there are more than 2000 pharmacies in Nanjing, Jiangsu Province.
according to the proportion of health insurance pharmacies 70%, the number of pharmacies involved in the implementation of the 4 plus 7 also reached more than 1000.
▍ these pharmacies, the impact of great recently, Xi'an Yikang, Shuyu civilians, ordinary people have announced the follow-up of 4 plus 7, and the hospital "the same price."
and Yifeng also issued an "emergency notice", if there are patients in 2 km other than Yifeng market institutions, purchased lower than Yifeng pharmacy retail price or member price of the same specifications of drugs, once verified, Yifeng will be the drug will be the minimum sales unit difference of 3 times returned. The impact of the
4 plus 7 on the entire pharmaceutical industry is gradually being demonstrated and is spreading to the retail market. Jia Xiaoqing, purchasing manager of the retail department of Jiangsu Pharmaceutical Co., Ltd. of
, told Seibrand that all medical insurance pharmacies in Nanjing will implement 4 plus 7, a change that will have a greater impact on small and medium-sized chain pharmacies, and retail pharmacies will face the problem of how existing stocks will make up the gap.
after all, small and medium-sized chains do not have such a strong bargaining power, if the new purchase price is not clearly in accordance with the case of 4 plus 7 or the original price, Nanjing City suddenly implemented 4 plus 7 health insurance price adjustment, will make some retail pharmacies caught off guard.
on the price issue, he believed that, at the current rate of judgment, industry should implement the same price for hospital retail.
if industrial companies do not give hospitals and pharmacies the same treatment, the 4 plus 7 varieties will disappear in some pharmacies.
however, since the medical insurance sector has chosen to implement a unified price system outside the hospital, it is certainly hoped that industrial enterprises can treat small and medium-sized chains in the same way as the same price, and truly implement the 4 plus 7 program to enable patients to purchase drugs.
▍ the spread of the impact range of 4 plus 7 about 4 plus 7, the first thing that comes to mind is that the hospital is cheap.
after the implementation of the 4-7 pilot, the same kind of difference in the pilot area and non-pilot areas is too large, as well as the hospital and pharmacy price gap in the pilot area is too large, causing many patients' dissatisfaction.
is precisely because of this difference, resulting in a large number of patients flocking to the pilot area hospitals to buy drugs, to a certain extent, affecting the medical order and drug supply.
For retail pharmacies, the huge difference in hospital retail sales brought about by the 4 plus 7 pilot has also caused some problems.
a pharmaceutical company to The seberlan said, because the previous 4 plus 7 pilot retail pharmacies did not participate in the drug companies to be supplied to the hospital according to the 4 plus 7 price, but the retail channels do not have this requirement, and the health care sector did not intervene, resulting in the 25 varieties in the drugstore is almost difficult to find, many varieties in the retail pharmacy are in the bottom of the state.
today, with the expansion of the 4 plus 7, more and more patients in more and more areas can enjoy the best prices simultaneously, which is the industry's development and progress, and this trend will continue.
According to the data of The Menet, a total of 61 products of 40 pharmaceutical companies won the bid in the 4-plus-7 pilot and 4-7 expansion, all products in 2018 in the retail terminal market accounted for only 4.2%, overall, the current collection of varieties of winning enterprises share is relatively small, the impact on the retail market is small.
with the continuous promotion of the policy of 4 plus 7, the range of varieties continues to expand, whether winning the bid or not, the public hospital market for pharmaceutical companies will be more and more uncertain, its demand for the retail market will gradually increase.
the future, with the rapid increase of drug diversion, prescription outflow, chain drugstores on the bargaining power of pharmaceutical companies continue to improve, there will be more pharmaceutical companies and chain pharmacies direct cooperation.
retailing, is one of the markets that pharmaceutical companies can't give up and must pay attention to.
original title: Exclusive - Thousands of pharmacies, starting with the execution of 4 plus 7.